Matteo joined AMAL in 2018 and is now Head of In Vivo Research.

Matteo has been working in the immunology research field for over 10 years, with experience in both academic and Biotech R&D. During his 7 years at the University of Lausanne, Matteo studied the immune response to Leishmania protozoan parasite infection focusing on both innate and adaptive immunity, and their interaction with hyperpathogenism and viral co-infection. After one year as post-doc, where he was involved in preclinical studies on a leishmaniasis vaccine, Matteo joined AMAL first as immunology scientist and then as senior scientist, acquiring a strong background in cancer vaccine and immunotherapy development, that led him to undertake many external and internal collaborations.

Matteo holds a PhD in Immunology from the University of Lausanne, Switzerland.

back to management team